T. Rowe Price Associates

T. Rowe Price Associates’s Strata Critical Medical Inc SRTA Stock Holding History

T. Rowe Price Associates’s Portfolio SRTA Stock Details SRTA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$173K	Buy
2025 Q2	$122K	Buy
2025 Q1	$68K	Buy
2024 Q4	$98K	Buy
2024 Q3	$60K	Buy
2024 Q2	$68K	Buy
2024 Q1	$46K	Buy
2023 Q4	$54K	Buy
2023 Q3	$34K	Buy
2023 Q2	$46K	Buy
2023 Q1	$37K	Buy